The FDA has authorized Mayo Clinic to offer mesenchymal stem cells as part of the Regenerative Nephrology Compassionate Use Program. This is an expanded access program.

Intestinal Stem Cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for treating intractable intestinal diseases due to their low risk of rejection ...

An expert sat down with CURE® and discussed how stem cells are collected before a patient with myeloma undergoes a stem cell transplant. A stem cell transplant is one of the most efficient tools to ...

The International Society for Stem Cell Research (ISSCR) today announced the 10 most downloaded papers of 2025 from Stem Cell ...

To date, more than 100 clinical trials with human pluripotent stem cell (hPSC)-derived products have been initiated worldwide ...

With a Kobe University-developed procedure, induced pluripotent stem cells can now be frozen directly in their dishes without ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...

SereNeuro Therapeutics revealed promising results for SN101, a first-in-class iPSC-derived therapy designed to treat chronic osteoarthritis pain while protecting joint tissue. Instead of blocking pain ...

Imagine if our bodies could grow new organs throughout our entire lives. Plants do this constantly, thanks to tiny, powerful ...

Colorectal cancer, or CRC, is the world's second most lethal cancer based on the number of deaths, and is the third most ...